We got our daughter back after these sessions
Chile ranks second globally in adolescent suicide rates, with 26.5% of teens showing moderate-to-severe depression/anxiety symptoms and suicide among top causes of death for ages 15-29. Treatment-resistant depression affects 25-40% of adolescents; TMS is FDA-approved for patients 15+ and achieves remission in 41% of cases and eliminates suicidal ideation in 60% of patients.
- Chile ranks second globally in adolescent suicide rates; 26.5% of teens show moderate-to-severe depression/anxiety
- 25-40% of depressed adolescents don't respond to standard medications; TMS achieves 70% response rate
- TMS eliminates suicidal ideation in 60% of patients and achieves depression remission in 41%
Chile faces a youth mental health crisis with 75% of adolescents experiencing anxiety or depression symptoms. Transcranial Magnetic Stimulation (TMS) emerges as an effective alternative for treatment-resistant cases, showing 70% response rates where traditional medications fail.
In Chile, three out of every four young people carry symptoms of anxiety or depression. The country ranks second globally in adolescent suicide rates, a distinction that arrives with a grim footnote: ninety percent of those deaths are tied to untreated mental illness. For families watching their teenagers sink into a darkness that resists every conventional remedy, the statistics feel less like data and more like a countdown.
Emilia was sixteen when her father Javier brought her to a psychiatrist for what would become the first of many attempts to pull her back. She had always been emotionally sensitive, he recalls—therapy since childhood, multiple medication trials, none of them landing. As she entered adolescence, depression took hold. Antidepressants came next, but Emilia rejected them. She grew reactive, withdrawn. Javier watched his daughter disappear into a condition doctors would eventually name: treatment-resistant depression. He was not alone in this vigil. Across Chile, families were knocking on the same doors, hearing the same explanations, finding the same empty hands.
The numbers tell part of the story. Government surveys show that 26.5 percent of Chilean adolescents display moderate to severe symptoms of anxiety and depression—a figure the government itself flagged as cause for concern. Suicide remains among the leading causes of death for people aged fifteen to twenty-nine, surpassing global averages tracked by the World Health Organization. And within the population of depressed youth, between twenty-five and forty percent do not respond to standard treatments: antidepressants, psychotherapy, the interventions that typically begin to work within two to three weeks. When those fail, the risk of suicidal ideation climbs sharply.
Dr. María José Arroyo, a child and adolescent psychiatrist at Brain Treatment Center Chile, defines the clinical threshold clearly: a young person with depression symptoms lasting more than a year, having tried at least two different medication regimens over six to eight weeks with no improvement, meets the definition of treatment-resistant depression. The body simply will not respond. The mind remains trapped. For these patients, conventional medicine has run out of answers.
Transcranial Magnetic Stimulation—TMS—enters the picture as a different kind of tool. It is not a drug. It is not talk therapy. Instead, an electromagnetic coil placed against the scalp generates a magnetic field that penetrates roughly two centimeters into the brain's cortex, modulating neural activity in the circuits that govern mood regulation. The procedure is non-invasive, painless, and approved by the FDA for patients as young as fifteen. The number of sessions is determined after initial evaluation. Dr. Arroyo notes that while forty percent of adolescents with depression prove resistant to medication, TMS offers a seventy percent response rate in those same patients—and without the side effects that often accompany pharmaceutical treatment.
When Emilia underwent TMS, the change arrived quickly. Within weeks, her father saw his daughter return. She became motivated again, her concentration sharpened, her mood lifted. The mornings that once required coaxing now found her ready first. The family recovered moments of lightness they thought were gone. Javier describes the transformation as "very impressive," a word that carries the weight of relief and astonishment.
Clinical evidence supports what families like Emilia's are experiencing. Research published in Clinical Neurophysiology documents that TMS achieves remission of depression in forty-one percent of adolescent patients, eliminates anxiety symptoms in one of every three, and erases active suicidal ideation in more than sixty percent of those who entered treatment with self-harm thoughts. Some of these changes appear within the first week. For families exhausted by failed treatments and the constant shadow of suicide risk, TMS represents not just another option but a genuine turning point—a moment when the door finally opens.
Citações Notáveis
Forty percent of adolescents with depression prove resistant to medication, but TMS offers a seventy percent response rate in those same patients—without the side effects of pharmaceutical treatment.— Dr. María José Arroyo, child and adolescent psychiatrist
We found in a short time the answers we were looking for in all the other treatments. Today we recovered our happy, affectionate daughter.— Javier, father of Emilia, 16
A Conversa do Hearth Outra perspectiva sobre a história
Why does Chile's rate of adolescent suicide stand out so sharply compared to other countries?
The country has a particular concentration of untreated mental illness among young people. Three-quarters of adolescents show anxiety or depression symptoms, and the healthcare system hasn't kept pace with the scale of need. When depression goes unaddressed, the risk compounds.
What makes depression "resistant" different from regular depression?
It's not that the person is resistant—it's that their brain chemistry doesn't respond to the standard medications. After a year of symptoms and two different drug regimens, nothing shifts. The person stays trapped while their suicide risk climbs.
How does TMS actually work inside the brain?
A magnetic coil creates a field that penetrates the cortex and rewires the circuits controlling mood. It's modulation, not medication. The brain responds where pills failed.
Is TMS available to most Chilean families, or is it still rare?
It's still concentrated in specialized centers. That's the gap. The evidence is strong—seventy percent response rates, remission in forty-one percent—but access remains limited. Families have to find their way to places like Brain Treatment Center.
What does recovery look like for a teenager who's been depressed for years?
Javier's daughter Emilia went from unable to get out of bed to being the first one ready in the morning. Concentration returned. Motivation returned. The family got their daughter back. But that only happens if they reach treatment in time.
What's the risk if TMS doesn't expand?
More adolescents will cycle through failed medications, their suicide risk rising with each failure. The window for intervention narrows. Families will keep knocking on doors that don't open.